RAD51 biomarker could complement next-generation sequencing in personalizing prostate cancer treatment
Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...
emjreviews.com1d
New Genetic Link to Hereditary Prostate Cancer Identified
A new study has identified pathogenic variants in WNT9B as significant risk factors for hereditary prostate cancer. Read more ...